Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol in beta-blocker intolerant cardiovascular patients
NCT00893984Phase 4Terminated
- Sponsor
- Minneapolis Heart Institute Foundation
- Start
- May 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nebivolol in coronary artery disease (CAD), sponsored by Minneapolis Heart Institute Foundation. Started May 2009; status: terminated.
02
Drugs
nebivolol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00893984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00893984.